Veeva Systems

How confident are you in your clinical reference data? Building the right foundation is the key for the industry’s push toward advanced analytics and AI. However, AI is only as good as the data it consumes. Learn more about the advantages of clean reference data: https://lnkd.in/g2t5-gkP

Today is #ClinicalTrialsDay! This year’s theme is #ResearchRising and our recent event in New Jersey very much felt that way. We gathered at our Clinical Data Innovation Forum and Workshop to celebrate the collective impact of everyone in the room. We discussed the future of risk-based data management, automation, and AI. The attendees came with a feeling of responsibility to translate ideas into action. That feeling of responsibility is what drives innovative teams working on a new treatment for a decade or more to ultimately help millions of patients. We must honor a legacy of innovation by not continuing with legacy ways of working! Thank you to the clinical data leaders I saw in New Jersey and to all clinical research pros for your tireless commitment to patients. Your dedication is worth celebrating every day, but especially today. #CTD2026

⚡️ #VeevaSummit is officially underway and tomorrow’s agenda is packed with biopharma leaders sharing AI successes and new approaches to commercial engagement. Thank you to our customers and partners who joined tonight’s Welcome Reception and helped us kick-off the week in Boston! 🎉 Don’t miss the Opening Keynote tomorrow morning as Veeva leaders Peter Gassner, Arno Sosna, and Chase Feiger, M.D. discuss the vision for Agentic Commercial, bringing together industry-specific AI, data, and applications to help the industry advance and deliver better medicine to more patients. Tips to plan your morning: 🎟️ 7:30 a.m. - Badge pickup opens (download the Veeva Events app for fast check-in!) 🥓🍳 7:30 a.m. - Breakfast 🎤 9 a.m. - Opening Keynote View the full agenda and room locations here: https://lnkd.in/eauCiycp See you tomorrow! 👋 #Biotechnology #Pharmaceuticals

Acadia Pharmaceuticals, BioMarin Pharmaceutical Inc., Boehringer Ingelheim, Curium Pharma and more share AI successes and explore new approaches to commercial engagement during #VeevaSummit livestreams. 🎥 Register here: https://lnkd.in/dSqjhhTb Watch 30+ keynotes, roadmaps, and industry leader sessions Tuesday and Wednesday, here's what to expect: 🚀 Fastest Path to AI with Vault CRM See how the Agentic Call Report provides Corcept Therapeutics and Crinetics Pharmaceuticals with Commercial Evidence that's uncovering treatment barriers tied to access, education, and resource challenges. 🤝 Conversational AI Watch how brand leaders use Veeva Ostro for instant, compliant conversational AI to drive deeper patient and HCP engagement. 🌟 Next-Gen Marketing Learn how biopharmas like Moderna are embedding AI into MLR, and how Novo Nordisk built a standardized agentic content ecosystem. 📊 Data-Driven Insights  Discover how Bayer and GSK turn high-scale data into actionable field intelligence. Hear how OpenData 2.0 provides clean, harmonized reference data to scale AI. 🩺 Modern Medical Affairs  See how Vertex Pharmaceuticals and MSL Mastery are building a modern operating system to improve scientific engagement and patient outcomes. 🛠️ Vault Platform Innovations Learn how Vault Platform is the single platform to handle data, content, and agents together. See a technical deep dive and learn how it serves as the agentic engagement platform for Vault CRM. #Biotechnology #Pharmaceuticals

Keenova moved away from siloed outsourcing to  partnering with Atorus, to gain full ownership over its clinical data using Veeva EDC and CDB. Here’s how Keenova bridged the gap between vision and execution: - SOP Collaboration: Accelerated study start times by leveraging Atorus’s SOPs, enabling Keenova to refine their standards during the study. - Speedy Validation: Bypassed the need for full-system validation by leveraging Veeva’s standard application, allowing the team to focus resources on study-specific validation. - Enhanced Oversight: Replaced manual trackers with real-time dashboards and automated Critical-to-Quality (CtQ) checks provided Keenova with superior operational visibility. Owning your data is easier than you think when you have the right tech and the right partner. #VeevaSummit #Biopharma #ClinicalData #DataManagement #Keenova #Atorus Hear more  https://lnkd.in/g8J6pQRm

Boehringer Ingelheim now has a single source of truth for clinical trials. Michael Haushalter, Senior Principal Capability Manager, shares how a unified platform facilitates collaboration between data management and clinical operations to deliver treatments faster. Watch the full story to see how they transformed their clinical development process: https://lnkd.in/gDPHXk-3 #ClinicalTrials #DigitalTransformation #LifeSciences

Bad clinical reference data can delay site startup and operations by weeks, leading to lost productivity and added trial costs. With clean data, clinical leaders can achieve: - Consistent, verified data at scale - Real-time, automated data maintenance - Operational efficiency and staff focus - A reliable data foundation for AI Learn more: https://lnkd.in/g2t5-gkP

In a recent article in ComputerWeekly.com, Bernard Seiser of AOP Health shares a clear view of what digital transformation needs to deliver in life sciences: fewer silos, stronger foundations, and end-to-end processes that help teams work with greater speed, transparency, and control. That is what makes this story so interesting. AOP Health is taking a connected approach across clinical, development, quality, and commercial, with a clear focus on building the right backbone first and creating room for better data, analytics, and AI over time. As Bernard says, the goal is to create a way of working where there are “no handovers, no breaks in the process,” with the same level of transparency and security throughout. A strong example of how digital leaders are helping shape the future of life sciences. https://lnkd.in/d3yKXVan

Architecting the AI-ready enterprise isn't about deploying technology everywhere at once, it's about pinpointing the exact value-generating processes where AI can deliver the biggest step change in performance. In the first episode of #WhatPharmaNeedsNext, Kieron Scrutton of GSK shares their story of identifying the essential building blocks required to scale AI safely and efficiently, and why keeping a human in the loop remains a top priority. Listen to the full podcast: https://lnkd.in/dTVjuEZE Spotify: https://lnkd.in/gyyAiW_D YouTube: https://lnkd.in/g8JVDPVD Apple Podcasts: https://lnkd.in/gC6ZsT3d #LifeSciences #VeevaAI